Search

Search Results

• Once-daily intravenous busulfan as myeloablative, reduced-toxicity conditioning regimen: results in young and adult patients with hematological malignant and nonmalignant diseases

  E Di Bartolomeo, S Santarone, P Bavaro, P Di Carlo, P Olioso, G Papalinetti, P Di Bartolomeo

  2009-06-23

  Published: June 23, 2009

  296

  PDF: 941

• 7TH HEREDITARY HEMORRHAGIC TELANGIECTASIA INTERNATIONAL SCIENTIFIC CONFERENCE

  Carlo Sabbà

  2009-06-16

  Published: June 16, 2009

  191

  PDF: 349

  PDF: 329

  PDF: 107

  PDF: 213